GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medican Enterprises MDCN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

—

FY2014FY2024

Net income

−$1.2m

FY2014FY2024

Free cash flow

−$21.2m

FY2014FY2024

Shareholders' equity

—

FY2014FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2014
Revenue——$2.6m$4.2m$1.1m$624,000—
Operating income−$2.0m−$925,000$738,663$428,230−$97,250$167,920−$57.5m
Net income−$1.2m$675,314$6.4m$152,653$3.8m$118,421−$56.5m
Diluted earnings per share-0.000.000.000.000.000.00-11.61

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2014
Total assets——$48.2m$43.5m$40.5m$41.2m$112,624
Cash and short-term investments——$75,304$359,806$25,000$15,000$79,624
Total liabilities——$19.8m$25.4m$27.9m$34.4m$8.4m
Debt——$19.8m$25.4m$27.9m$34.4m$5.9m
Shareholders' equity——$28.4m$18.1m$12.6m$6.8m−$8.3m
Shares outstanding41,402m38,945m38,945m33,240m10,093m44,645m5m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2014
Cash from operations−$21.2m$153,703$6.0m$1.2m$13.7m$291,080−$3.0m
Capital spending−$3−$3−$4−$4———
Free cash flow−$21.2m$153,700$6.0m$1.2m$13.7m$291,080−$3.0m

Latest quarters

By quarter end

Mar 2025Dec 2024Jun 2024Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021
Revenue$936,872——$664,511$870,160$1.1m$1.2m$1.2m
Operating income$789,425−$1.7m−$232,000$253,479$808,510−$323,000$372,830$337,800
Net income$789,425−$948,000$557,906$4.2m$77,898$6.0m$372,828$62,225
Diluted earnings per share0.00-0.000.000.000.000.000.000.00
Cash from operations—−$19.0m—$4.0m—$5.0m——
Total assets———$48.2m$48.7m$48.4m$43.5m$43.0m
Cash and short-term investments———$75,304$304,958$495,049$359,806$290,526
Shareholders' equity———$28.4m$24.2m$24.1m$18.1m$17.4m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income——72.4%
Net income——63.9%

Valuation history

At each fiscal year end

FY2024FY2023
Price to earnings-0.30.6

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return900%0%6300%6553500%300%900%300%204700%409500%0%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 20 Apr 2015
  • 20-for-1 split · 26 Sept 2013
  • 4-to-1 reverse split · 26 Nov 2010
  • 2.3943-for-1 split · 31 Dec 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.